| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Lorcaserin (Belviq, Belviq XR) (CP.PCH.03) - RETIRED (Ambetter June 1, 2022) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Cerliponase alfa (Brineura) (TX.PHAR.46) - RETIRED (Medicaid January 24, 2022) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Pegademase Bovine (Adagen) (CP.PHAR.392) - RETIRED (Medicaid and Ambetter December 1, 2021 | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Human Growth Hormone (Somapacitan, Somatropin) (CP.PCH.39) - RETIRED (Ambetter December 1, 2021) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Bremelanotide (Vyleesi) (CP.PHAR.434) - RETIRED (Ambetter December 1, 2021) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Handling Authorizations for Transportation (TX.UM.10.07) - RETIRED (Medicaid November 1, 2021 | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Mogamulizumab-kpkc (Poteligeo) (CP.PHAR.139) - RETIRED (Medicaid October 18, 2021) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Rituximab - Effective 11/1/2017 (CP.PHAR.260) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Naloxone (Evzio) (CP.PMN.139) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Influenza Testing | |